Induction of cytotoxic T cells and their antitumor activity in mice transgenic for carcinoembryonic antigen.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 285, doi. 10.1007/s002620000116
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2000 AND VI 49 AND IP 6
Results: 7
1
2
Resistance of ex vivo expanded CD3<sup>+</sup>CD56<sup>+</sup> T cells to Fas-mediated apoptosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 335, doi. 10.1007/s002620000111
- By:
- Publication type:
- Article
3
A low-level expression of human MUC1 mucin enhances lethality of murine tumor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 305, doi. 10.1007/s002620000117
- By:
- Publication type:
- Article
4
Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 319, doi. 10.1007/s002620000110
- By:
- Publication type:
- Article
5
Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 325, doi. 10.1007/s002620000121
- By:
- Publication type:
- Article
6
α<sub>v</sub>β<sub>3</sub> expression on blood vessels and melanoma cells in primary lesions; differential association with tumor progression and clinical prognosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 314, doi. 10.1007/s002620000124
- By:
- Publication type:
- Article
7
Development of a new vaccine formulation that enhances the immunogenicity of tumor-associated antigen CaMBr1.
- Published in:
- Cancer Immunology, Immunotherapy, 2000, v. 49, n. 6, p. 296, doi. 10.1007/s002620000113
- By:
- Publication type:
- Article